Diabetes and Pancreatic Cancer

  • Saira Burney Department of Endocrinology & Metabolism, Services Hospital. Lahore, Pakistan
  • Khadija Irfan Department of Endocrinology & Metabolism, Services Hospital. Lahore, Pakistan
  • Muhammad Wasif Saif Tufts Medical Center and Tufts Cancer Center. Boston, MA, USA
  • Faisal Masud King Edward Medical University. Lahore, Pakistan
Keywords: Diabetes Mellitus, Hyperinsulinism, Neoplasms, Pancreatic Neoplasms

Abstract

Research suggests a possible link between type 2 diabetes and several malignancies. Animal models have shown that hyperinsulinemic state underlying diabetes promotes tumor formation through stimulation of insulin-IGF-1 pathway; a possible role of inflammation is also proposed. One such link which has been under considerable study for years is that between diabetes and pancreatic cancer. Although epidemiological evidence points towards a reciprocal link between the two, the cause-effect relationship still remains unclear. This link was the subject of a large German epidemiological study presented at the American Society of Clinical Oncology Annual Meeting 2014 (Abstract #1604), which underscored the link between diabetes and some cancers. Schmidt et al. performed a retrospective database analysis over a 12 year period and reported an increased risk of certain types of cancer in diabetic patients. The most significant association (HR 2.17) was found for pancreatic cancer. Given the high mortality of pancreatic cancer, prevention through timely screening could play an important role in improving prognosis. Older subjects with recent-onset diabetes represent a high-risk group and hence are potential targets for pancreatic cancer screening thereby enabling its early diagnosis at a curable stage.

Image: Services Hospital logo. Lahore, Pakistan.

Downloads

Download data is not yet available.

References

Jemal A, Siegal R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin. 2006; 56: 106-30. [PMID:16514137]

Niederhiber JE, Brennan MF, Menck HR. The National Cancer DataBase report on pancreatic cancer. Cancer. 1995; 76: 1671-7. [PMID:8635074]

Ben Q, Cai Q, Li Z, Yuan Y, Ning X, Deng S, Wang K. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer. 2011; 47(2): 248-54. [PMID:20709528]

Chu CK, Mazo AE, Goodman M, Egnatashvili V, Sarmiento JM, Staley CA, Galloway JR, et al. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Ann SurgOncol. 2010; 17(2): 502-13. [PMID:19885697]

Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe K D, Swanson G M, Schwartz A G, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999; 80(11): 1830-1837. [PMC:2363127]

Pezzilli R, Pagano N. Is Diabetes Mellitus a risk factor for Pancreatic cancer? World J Gastroenterol. 2013; 14; 19(30): 4861-6. [PMID:7745774]

Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012; 35(11): 2402-11. [PMID:23093685]

Li J, Cao G, Ma Q, Liu H, Li W, Han L. The bidirectional interaction between pancreatic cancer and diabetes. World J Surg Oncol. 2012; 24: 10: 171. [PMID:22920886]

Chari ST, Leibson CL, RabeKG,Timmons LJ, Ransom J, de Andrade M, Petersen GM. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology. 2008; 134(1): 95-101. [PMID:18061176]

Gullo L, Pezzilli R, Morselli-Labate AM. Diabetes and the risk of pancreatic cancer. Italian Pancreatic Cancer Study Group. N Engl J Med.1994; 331: 81-4.

Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. JAMA. 1995; 273: 1605-1609. [PMID:7745774]

Huxley R, Ansary-Moghaddam, Berrington de Gonzalez A, Barzi F, Woodward M. Type II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005; 92: 2076-2083. [PMID:15886696]

Handelsman Y, Leroith D, Bloomgarden ZT, Dagogo-Jack S, Einhorn D, Garber AJ, Grunberger G, et al. Diabetes and cancer-An AACE/ACE consensus statement. Endocr Pract. 2013; 19(4): 675-693. [PMID:23978590]

Cui YF, Andersen DK. Diabetes and pancreatic cancer. Endocr-Relat Cancer. 2012; 19: F9-F26.

Pannala R, Leirness JB, Bamlet WR, Basu A, Peterson GM, Chari ST. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008; 134: 981-987. [PMC:2323514]

Fogar P, Pasquali C, Basso D, Sperti C, Panozzo MP, Tessari G, D'Angeli F, et al. Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res. 1994; 14(6B): 2827-2830. [PMID:7532931]

Li D. Diabetes and pancreatic cancer. Mol Carcinog. 2012; 51(1): 64-74. [PMID:22162232]

Schmidt N, Kostev K, Ziller V, Kowall B, Rathmann W. Association of diabetes and cancer-diagnoses in primary care practices in Germany. J Clin Oncol.2014; 32 (5 suppl): 1604.

Services Hospital logo. Lahore, Pakistan
Published
2014-07-28
How to Cite
BurneyS., IrfanK., SaifM., & MasudF. (2014). Diabetes and Pancreatic Cancer. JOP. Journal of the Pancreas, 15(4), 319-321. https://doi.org/10.6092/1590-8577/2680
Section
Highlights from the “50th ASCO Annual Meeting 2014”. Chicago, IL, USA. May 30 - June 3, 2014

Most read articles by the same author(s)